251 related articles for article (PubMed ID: 24657661)
21. Direct transplantation of chronic myelogenous leukemia cells into nude mice and establishment of a leukemic stem cell (Ph1+, CD34+) line dependent on mouse bone marrow stromal cells in vitro.
Kubonishi I; Takeuchi S; Uemura Y; Kamioka M; Asahi Y; Ohtsuki Y; Miyoshi I
Jpn J Cancer Res; 1995 May; 86(5):451-9. PubMed ID: 7540608
[TBL] [Abstract][Full Text] [Related]
22. BM microenvironmental protection of CML cells from imatinib through Stat5/NF-κB signaling and reversal by Wogonin.
Xu X; Zhang X; Liu Y; Yang L; Huang S; Lu L; Wang S; Guo Q; Zhao L
Oncotarget; 2016 Apr; 7(17):24436-54. PubMed ID: 27027438
[TBL] [Abstract][Full Text] [Related]
23. Preservation of Quiescent Chronic Myelogenous Leukemia Stem Cells by the Bone Marrow Microenvironment.
Shah M; Bhatia R
Adv Exp Med Biol; 2018; 1100():97-110. PubMed ID: 30411262
[TBL] [Abstract][Full Text] [Related]
24. Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21.
Taverna S; Giallombardo M; Pucci M; Flugy A; Manno M; Raccosta S; Rolfo C; De Leo G; Alessandro R
Oncotarget; 2015 Sep; 6(26):21918-33. PubMed ID: 26116834
[TBL] [Abstract][Full Text] [Related]
25. Integrin-mediated regulation of hematopoiesis: do BCR/ABL-induced defects in integrin function underlie the abnormal circulation and proliferation of CML progenitors?
Verfaillie CM; Hurley R; Lundell BI; Zhao C; Bhatia R
Acta Haematol; 1997; 97(1-2):40-52. PubMed ID: 8980609
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of heme oxygenase-1 in bone marrow stromal cells promotes microenvironment-mediated imatinib resistance in chronic myeloid leukemia.
Liu P; Ma D; Yu Z; Zhe N; Ren M; Wang P; Yu M; Huang J; Fang Q; Wang J
Biomed Pharmacother; 2017 Jul; 91():21-30. PubMed ID: 28445830
[TBL] [Abstract][Full Text] [Related]
27. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.
Li S; Ilaria RL; Million RP; Daley GQ; Van Etten RA
J Exp Med; 1999 May; 189(9):1399-412. PubMed ID: 10224280
[TBL] [Abstract][Full Text] [Related]
28. Chronic myeloid leukemia-derived exosomes attenuate adipogenesis of adipose derived mesenchymal stem cells via transporting miR-92a-3p.
Wan Z; Chen X; Gao X; Dong Y; Zhao Y; Wei M; Fan W; Yang G; Liu L
J Cell Physiol; 2019 Nov; 234(11):21274-21283. PubMed ID: 31062357
[TBL] [Abstract][Full Text] [Related]
29. The biology of chronic myelogenous leukemia:mouse models and cell adhesion.
Wertheim JA; Miller JP; Xu L; He Y; Pear WS
Oncogene; 2002 Dec; 21(56):8612-28. PubMed ID: 12476308
[TBL] [Abstract][Full Text] [Related]
30. Establishment of a new Glivec-resistant chronic myeloid leukemia cell line, SNUCML-02, using an in vivo model.
Park J; Kim KI; Koh Y; Won NH; Oh JM; Lee DS; Kim BK; Ahn KS; Yoon SS
Exp Hematol; 2010 Sep; 38(9):773-81. PubMed ID: 20438801
[TBL] [Abstract][Full Text] [Related]
31. Adhesion to stromal cells mediates imatinib resistance in chronic myeloid leukemia through ERK and BMP signaling pathways.
Kumar A; Bhattacharyya J; Jaganathan BG
Sci Rep; 2017 Aug; 7(1):9535. PubMed ID: 28842696
[TBL] [Abstract][Full Text] [Related]
32. Increased phosphorylation of eIF2α in chronic myeloid leukemia cells stimulates secretion of matrix modifying enzymes.
Podszywalow-Bartnicka P; Cmoch A; Wolczyk M; Bugajski L; Tkaczyk M; Dadlez M; Nieborowska-Skorska M; Koromilas AE; Skorski T; Piwocka K
Oncotarget; 2016 Nov; 7(48):79706-79721. PubMed ID: 27802179
[TBL] [Abstract][Full Text] [Related]
33. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
34. Leukemia-derived exosomes induced IL-8 production in bone marrow stromal cells to protect the leukemia cells against chemotherapy.
Chen T; Zhang G; Kong L; Xu S; Wang Y; Dong M
Life Sci; 2019 Mar; 221():187-195. PubMed ID: 30716336
[TBL] [Abstract][Full Text] [Related]
35. Lung tumor exosomes induce a pro-inflammatory phenotype in mesenchymal stem cells via NFκB-TLR signaling pathway.
Li X; Wang S; Zhu R; Li H; Han Q; Zhao RC
J Hematol Oncol; 2016 Apr; 9():42. PubMed ID: 27090786
[TBL] [Abstract][Full Text] [Related]
36. High IL-7 levels in the bone marrow microenvironment mediate imatinib resistance and predict disease progression in chronic myeloid leukemia.
Zhang X; Tu H; Yang Y; Wan Q; Fang L; Wu Q; Li J
Int J Hematol; 2016 Sep; 104(3):358-67. PubMed ID: 27272942
[TBL] [Abstract][Full Text] [Related]
37. Curcumin modulates chronic myelogenous leukemia exosomes composition and affects angiogenic phenotype via exosomal miR-21.
Taverna S; Fontana S; Monteleone F; Pucci M; Saieva L; De Caro V; Cardinale VG; Giallombardo M; Vicario E; Rolfo C; Leo GD; Alessandro R
Oncotarget; 2016 May; 7(21):30420-39. PubMed ID: 27050372
[TBL] [Abstract][Full Text] [Related]
38. Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia.
Jin Y; Zhou J; Xu F; Jin B; Cui L; Wang Y; Du X; Li J; Li P; Ren R; Pan J
J Clin Invest; 2016 Oct; 126(10):3961-3980. PubMed ID: 27643437
[TBL] [Abstract][Full Text] [Related]
39. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
Kometani K; Aoki M; Kawamata S; Shinozuka Y; Era T; Taniwaki M; Hattori M; Minato N
Cancer Res; 2006 Oct; 66(20):9967-76. PubMed ID: 17047059
[TBL] [Abstract][Full Text] [Related]
40. BCR-ABL1-positive microvesicles malignantly transform human bone marrow mesenchymal stem cells in vitro.
Fu FF; Zhu XJ; Wang HX; Zhang LM; Yuan GL; Chen ZC; Li QB
Acta Pharmacol Sin; 2017 Nov; 38(11):1475-1485. PubMed ID: 28836580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
